Nora Shields1, Nicholas F Taylor, Karen J Dodd. 1. Musculoskeletal Research Centre and the School of Physiotherapy, La Trobe University, Melbourne, Australia. N.Shields@latrobe.edu.au
Abstract
OBJECTIVE: To determine whether progressive resistance training improves muscle strength, muscle endurance, and physical function in adults with Down syndrome. DESIGN: Single-blind randomized controlled trial. SETTING: General community. PARTICIPANTS: Adults (N=20) with Down syndrome (13 men, 7 women; mean age, 26.8+/-7.8 y) were randomly assigned through a concealed allocation block randomized method to either an intervention group (n=9) or a control group (n=11). INTERVENTION: The intervention was a supervised, group progressive resistance training program, consisting of 6 exercises using weight machines performed twice a week for 10 weeks. Participants completed 2 to 3 sets of between 10 to 12 repetitions of each exercise until they reached fatigue. The control group continued with their usual activities. MAIN OUTCOME MEASURES: The outcomes measured by blinded assessors were muscle strength (1-repetition maximum [1-RM]), muscle endurance (number of repetitions at 50% of 1-RM) for chest press and leg press, timed stairs test, and the grocery shelving task. RESULTS: The intervention group showed significant improvement in upper-limb muscle endurance compared with the control group (mean difference in the number of repetitions of the chest press at 50% of 1-RM was 16.7, 95% confidence interval, [CI] 7.1-26.2); and a trend toward an improvement in upper-limb muscle strength (mean difference in chest press 1-RM, 8.6 kg; 95% CI, -1.3 to 18.5 kg) and in upper-limb function (mean difference in grocery shelving task, -20.3s; 95% CI, -45.7 to 5.2s). There were no significant differences between the groups for lower-limb muscle performance or physical function measures. No major adverse events for the intervention were noted. CONCLUSIONS:Progressive resistance training is a safe and feasible fitness option that can improve upper-limb muscle endurance in adults with Down syndrome (ACTR identifier ACTRN 012606000515594.).
RCT Entities:
OBJECTIVE: To determine whether progressive resistance training improves muscle strength, muscle endurance, and physical function in adults with Down syndrome. DESIGN: Single-blind randomized controlled trial. SETTING: General community. PARTICIPANTS: Adults (N=20) with Down syndrome (13 men, 7 women; mean age, 26.8+/-7.8 y) were randomly assigned through a concealed allocation block randomized method to either an intervention group (n=9) or a control group (n=11). INTERVENTION: The intervention was a supervised, group progressive resistance training program, consisting of 6 exercises using weight machines performed twice a week for 10 weeks. Participants completed 2 to 3 sets of between 10 to 12 repetitions of each exercise until they reached fatigue. The control group continued with their usual activities. MAIN OUTCOME MEASURES: The outcomes measured by blinded assessors were muscle strength (1-repetition maximum [1-RM]), muscle endurance (number of repetitions at 50% of 1-RM) for chest press and leg press, timed stairs test, and the grocery shelving task. RESULTS: The intervention group showed significant improvement in upper-limb muscle endurance compared with the control group (mean difference in the number of repetitions of the chest press at 50% of 1-RM was 16.7, 95% confidence interval, [CI] 7.1-26.2); and a trend toward an improvement in upper-limb muscle strength (mean difference in chest press 1-RM, 8.6 kg; 95% CI, -1.3 to 18.5 kg) and in upper-limb function (mean difference in grocery shelving task, -20.3s; 95% CI, -45.7 to 5.2s). There were no significant differences between the groups for lower-limb muscle performance or physical function measures. No major adverse events for the intervention were noted. CONCLUSIONS: Progressive resistance training is a safe and feasible fitness option that can improve upper-limb muscle endurance in adults with Down syndrome (ACTR identifier ACTRN 012606000515594.).
Authors: L T Ptomey; B C Helsel; D A White; J Lee; J R Sherman; R A Washburn; A M Gorczyca; J E Donnelly Journal: J Intellect Disabil Res Date: 2022-02-21
Authors: G Fornieles; M A Rosety; S Elosegui; J M Rosety; J R Alvero-Cruz; N Garcia; M Rosety; T Rodriguez-Pareja; R Toro; M Rosety-Rodriguez; F J Ordonez; I Rosety Journal: Braz J Med Biol Res Date: 2014-03-28 Impact factor: 2.590
Authors: Jessica Stander; Jennifer C du Preez; Chantel Kritzinger; Natasha M Obermeyer; Silke Struwig; Nikki van Wyk; Jessica Zaayman; Marlette Burger Journal: S Afr J Physiother Date: 2021-05-20